VEGF-2 gene therapy (Northwestern University)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVEGF-2 gene therapy (Northwestern University)
Drug Alias NamephVEGF165
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionVascular endothelial growth factor receptor stimulants
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsDiabetic Neuropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSt Elizabeth'S Medical Center Of Boston
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNorthwest UniversitySt Elizabeth'S Medical Center Of Boston
Active IndicationsN/A
Inactive IndicationsDiabetic Neuropathies

Other Information

ATC CodeN/A
Related LinksN/A